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recent data on infectious complications and related risk
factors after lower extremity open and endovascular
revascularization on a national basis, the Swedvasc registry.
Certainly, such a study based on a nationwide registry is
very interesting for clinical practice since it reﬂects the real
life.
The goal of the study was to provide a means of
assessing the choice of treatment, open versus endovas-
cular surgery, and likely outcomes for different patients
categories. It is obviously interesting to know the impact of
a procedure on a general variable such as health-care
associated infections.
However, several limitations should be pointed out.
1. During the selected period, the study included 10,547
patients from the total number of 13,310 patients
treated during the period: the authors excluded 2,763
patients treated for reinterventions or with hybrid
procedures, corresponding to about 20% of the overall
population. They excluded hybrid procedures to
facilitate comparison between open and endovascular
surgery, but this latter group of patients should have
been considered in the study since it is a signiﬁcant and
speciﬁc group of patients in current clinical practice.
Excluding speciﬁc populations (20%) to increase the
strength of statistical analysis in a registry, which has per
se its proper weaknesses, is questionable.
2. In the ﬁrst part of their study the authors determined
the main risk factors for the 30-day overall infection
rate. These data are clinically relevant but the major
drawback is that the design of the registry did not
allow differentiating risk factors for each site of
infection. Moreover, risk factors should have been
more precisely deﬁned to allow preventive strategies in
clinical practice. As an example, patients with stable
and controlled diabetes have the same infection risk as
non-diabetic patients.2,3 It is obviously a limitationDOI of original article: http://dx.doi.org/10.1016/j.ejvs.2014.02.003
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http://dx.doi.org/10.1016/j.ejvs.2014.04.014related to a registry design. Finally, postoperative
infection rate is inﬂuenced by antibiotic prophylaxis
that can be adapted in patients depending on the
occurrence of distal infection at the time of the
procedure. This variable has not been studied, also
because of the registry design.
3. In a second step, authors tried to evaluate the
potential role of overall infection rate on 30-day
mortality and amputation rate. The disappearance of
signiﬁcant variables in univariate analysis after
multivariate analysis conﬁrms the presence of
confusion biases mainly because the primary endpoint,
postoperative infection, is too general and includes
different pathologies and presentations. It is clear that
infection directly inﬂuences mortality rates in an
elderly population with associated comorbidities. As an
example, patients with chronic obstructive pulmonary
disease have a higher risk of postoperative pulmonary
infection and death after general anesthesia for open
surgery rather than after an endovascular procedure
performed under local anesthesia. Mortality rates
associated with infected vascular grafts also strongly
depend on the type of treatment proposed.
Amputation rate is mainly related to the necessity of
infected graft deposition in patients suffering critical
limb ischemia and requiring such a bypass for limb
salvage rather than for a claudicant patient requiring
an amputation because of an extremely severe shock
secondary to a urinary infection. Unfortunately, the
role, incidence, and predictive factors for infections
that lead to the failure of the arterial reconstruction
could not be evaluated in the present study because of
its design.
4. The last point is that authors concluded on the role of
the type of procedure, open versus endovascular, on
the infection rates. However, because of the design of
the study, a nationwide registry, there is no clear
information about the policies for the choice of the
technique on a patient depending on his
comorbidities.
In conclusion, this paper provides interesting insight on
health-care-associated infections after lower extremity
open or endovascular revascularizations. However, a critical
view on the methods used and the potential biases is
mandatory to adequately interpret the presented results.
European Journal of Vascular and Endovascular Surgery Volume 48 Issue 1 p. 78e79 July/2014 79Further research with a higher level of evidence is required
if we want to compare open to endovascular surgery
infection-related complications.
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